Diindolylmethane in Healthy Volunteers
Completed · Phase 1
Conditions studied: Healthy, no Evidence of Disease
In brief
This randomized phase I trial is studying the side effects and best dose of diindolylmethane in healthy volunteers. Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back. The use of diindolylmethane may keep cancer from forming. Collecting and storing samples of blood and urine from healthy volunteers to study in the laboratory may help doctors learn more about the way a person's body handles the drug.
Key facts
- Study ID
- NCT00392652
- Run by
- National Cancer Institute (NCI)
- People needed
- 14
- Starts
- 2006-11-01
- Expected to finish
- 2009-10-01
- Last updated by the study team
- 2016-12-29
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Kansas Medical Center — Kansas City, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.